Question 1

Am I eligible for this trial based on my current health and cancer status?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer clinical trial (NCT07409272). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential benefits and risks of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer clinical trial (NCT07409272). Contact the study team or your healthcare provider for specific answers.

Question 3

How does setidegrasib compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer clinical trial (NCT07409272). Contact the study team or your healthcare provider for specific answers.

Question 4

What will my treatment schedule look like if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer clinical trial (NCT07409272). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any side effects I should be aware of with setidegrasib and the chemotherapy?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer clinical trial (NCT07409272). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my health be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer clinical trial (NCT07409272). Contact the study team or your healthcare provider for specific answers.

What this study is about